Trial record 12 of 31 for:    Acorda

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis

This study is currently recruiting participants.
Verified March 2014 by Acorda Therapeutics
Sponsor:
Collaborator:
PRA International
Information provided by (Responsible Party):
Acorda Therapeutics
ClinicalTrials.gov Identifier:
NCT01803867
First received: February 26, 2013
Last updated: March 6, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)